GLP-1 prior authorization often takes two to six weeks, and sometimes longer. It is not one review but several handoffs between your provider, your pharmacy benefit manager, and your plan's formulary rules. Understanding the steps helps you know what is normal and what your options are if you cannot afford to keep waiting.
Prior authorization takes so long because your plan is checking multiple boxes in sequence, not one. Diagnosis codes, weight history, prior attempts at other treatments, and formulary tier all get reviewed, often by different desks. While that process runs, cash-pay compounded treatment is available now, with no prior authorization step at all.
Start your intake →What prior authorization actually is
Prior authorization is a request your prescriber sends to your insurance plan asking permission to cover a specific medication before the pharmacy will fill it. It exists because GLP-1 medications sit on a high-cost tier for most formularies, and plans want documentation before they pay.
The request usually needs your diagnosis code, your body mass index or related lab values, and notes on prior weight-management attempts. Sometimes it also needs a statement that you tried and failed a less expensive alternative first. None of this happens instantly, because each piece has to be pulled from your chart and typed into a plan-specific form.
Many plans use a separate pharmacy benefit manager to process the request rather than reviewing it in-house. That handoff alone can add several business days before anyone even opens your file. It is one of the least visible parts of the whole process to a patient waiting at home.
Why it takes weeks instead of days
Four things typically stack up to create the delay. First, your provider's office has to submit a complete request, and incomplete submissions get sent back rather than approved with a note attached. Second, the plan has its own internal queue, and GLP-1 requests are common enough that many pharmacy benefit managers are processing a large volume at once.
Third, some plans require step therapy, meaning you must show you tried a different, usually cheaper medication first and it did not work well enough. Documenting that history takes time if it was not tracked carefully in your chart to begin with.
Fourth, if anything in the request looks incomplete or inconsistent, the plan issues a request for more information rather than a denial. That request restarts part of the clock, because your provider's office then has to gather the missing piece and resubmit before review can continue.
None of this means your provider is doing something wrong. It means the review genuinely has several sequential steps, and each one has its own processing window that your provider's office cannot fully control on its own.
Key takeaway: A slow prior authorization is usually a sign of a normal, multi-step review process, not evidence that anything has gone wrong. Normal and fast are not the same thing, and you are allowed to look for a faster path while you wait.
How employer plans differ from marketplace plans
Not every plan handles GLP-1 requests the same way, and the differences affect how long yours will take. Large employer plans often carve out weight-management drugs entirely, meaning no amount of documentation changes the outcome because the exclusion sits at the plan-design level, not the individual review level.
Marketplace and smaller group plans are more likely to actually run a clinical review, which is slower but at least leaves room for an approval. If you do not know which category your plan falls into, ask your benefits administrator directly whether weight-management medication is excluded by plan design or reviewed case by case. That single question can save weeks of waiting on a request that was never going to be approved.
What you can do while you wait
Call your plan directly and ask for the specific status, not just whether it is approved. Ask what information, if any, is still outstanding, and ask your provider's office to confirm the request was actually submitted rather than left sitting in a draft queue.
Keep a simple written record of every call, including the date and the name of whoever you spoke with. If the request eventually gets denied and you decide to appeal, that record becomes useful evidence that you followed up in good faith throughout the process.
If your plan requires step therapy, ask exactly which alternative medication satisfies that requirement and for how long you need to have tried it. Some plans accept documentation from years ago, and some require a recent attempt, and that difference alone can change your timeline by months.
If the wait is putting your health on hold in the meantime, you do not have to sit still. Start an online visit and keep your insurance appeal running in parallel rather than waiting on one path before trying the other.
When the wait ends in a denial
A meaningful share of prior authorization requests for GLP-1 medications end in a denial rather than an approval, even after the full wait. Common reasons include a formulary exclusion for weight-loss indications, a body mass index that falls just under the plan's threshold, or missing documentation of a prior treatment attempt.
You generally have the right to appeal, and appeals sometimes succeed where the original request did not, particularly if new documentation gets added. But an appeal adds more weeks on top of the weeks you already spent waiting, with no assurance the second decision comes out differently.
If your health, your schedule, or your budget cannot absorb another open-ended wait, it helps to know what is available outside the insurance queue. That option can start today, rather than after another review cycle.
The cash-pay alternative that skips the queue
Compounded GLP-1 treatment through TelosRX does not go through prior authorization at all, because it is a cash-pay service rather than an insurance claim. There is no formulary tier to clear and no pharmacy benefit manager to route your request through.
Compounded semaglutide starts as low as $99 a month, and compounded tirzepatide starts as low as $139 a month. Both are prepared by partner compounding pharmacies and are not FDA-approved, which is a different regulatory category from the brand-name product your plan may still be reviewing.
Intake is asynchronous, meaning you complete an online visit and a licensed provider reviews it on their own schedule. There is no live appointment slot to book and no waiting room, virtual or otherwise, standing between you and a decision.
To be direct about the tradeoff: this is a different path, not an insurance-covered one. No insurer, including Medicare or Medicaid, covers compounded medication, and telos rx does not claim otherwise. What it offers is a way to start treatment now, at a transparent monthly price. Your insurance process can keep running on its own timeline in the background if you choose to keep pursuing it.
See if you qualify for compounded GLP-1 treatment without waiting on a prior authorization decision.
If needles are part of why you are stuck
Some people delay starting anything, insurance or cash-pay, because the idea of a weekly injection is the real obstacle rather than the paperwork. If that describes you, a needle-free oral GLP-1 is available from $9 a day, dispensing oral semaglutide or oral tirzepatide depending on what a clinician determines fits you.
There is also a lower-dose microdosed tirzepatide protocol, as low as $116 a month, built for people who want a gentler introduction to this medication class. Any of these options is subject to medical approval by a licensed provider, and none replaces a conversation with your own doctor about your specific health history.
Using FSA or HSA funds instead of insurance
Even though insurance does not cover compounded medication, that is a separate question from whether your FSA or HSA can pay for it. TelosRX plans are FSA and HSA eligible, which means pretax dollars you have already set aside can typically be applied toward the monthly cost.
This matters for the prior authorization wait specifically, because many people set aside FSA or HSA funds expecting to use them on a brand-name prescription once approved. If that approval keeps slipping, those same funds can often be redirected toward a compounded option instead, without waiting for a plan decision that may or may not arrive on your timeline.
Check your specific plan's rules before assuming eligibility, since FSA and HSA administrators vary in what documentation they require. Some ask for a letter of medical necessity before reimbursing a compounded prescription.
Weighing the two paths side by side
It helps to think of this as two separate tracks rather than one decision. Track one is your insurance appeal or ongoing prior authorization, which may eventually succeed and is worth pursuing if a brand-name medication is genuinely your preference. Track two is cash-pay compounded treatment, available immediately, at a fixed and known monthly price.
These tracks are not mutually exclusive. Plenty of people start compounded treatment now and simply let their insurance appeal continue in the background, switching later if it succeeds and they prefer to. Start your intake today if waiting any longer is not a realistic option for you.
Frequently Asked Questions
How long does GLP-1 prior authorization usually take?
Most requests take between two and six weeks from submission to a final decision, though timelines vary widely by plan. Delays are common when documentation is incomplete or when a plan requires proof of a prior treatment attempt.
Can I speed up my prior authorization?
Sometimes. Two steps help most. Call your plan to confirm the request was received and complete, and ask your provider's office to respond quickly to any request for more information.
What happens if my prior authorization is denied?
You typically have the right to appeal, and an appeal can succeed with stronger documentation. It also adds more time on top of the original wait, so many people look into other options rather than waiting through a second review cycle.
Does insurance cover compounded GLP-1 medication while I wait?
No. Insurance, Medicare, and Medicaid do not cover compounded medication. Compounded treatment through telos rx is a cash-pay option available now, separate from whatever your insurance plan eventually decides about a brand-name product.
Can I use FSA or HSA funds for compounded GLP-1 treatment?
Yes, telos rx plans are FSA and HSA eligible, so pretax funds can generally be applied toward the monthly cost. Confirm the specific eligibility rules with your own plan administrator before assuming coverage.
Is compounded GLP-1 medication the same as the brand-name drug?
No. Compounded medication is prepared by a licensed compounding pharmacy and is not FDA-approved, which is a different regulatory pathway from an approved brand-name product. It is a different option, offered as an alternative, not a copy of any specific brand.
TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service. For general background on this medication class, see the NIH NIDDK overview of prescription weight-management medication. For how compounded medication is regulated, see the FDA overview of drug compounding.
Tired of waiting on a decision? Message the TelosRX care team or start your evaluation at TelosRX.